Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.22 USD | +2.52% | -12.86% | +4.27% |
May. 13 | HC Wainwright Adjusts Price Target on Clearside Biomedical to $5 From $6, Keeps Buy Rating | MT |
May. 09 | Transcript : Clearside Biomedical, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Financials (USD)
Sales 2024 * | 582K | Sales 2025 * | 7.36M | Capitalization | 91.17M |
---|---|---|---|---|---|
Net income 2024 * | -42M | Net income 2025 * | -42M | EV / Sales 2024 * | 120 x |
Net cash position 2024 * | 21.26M | Net Debt 2025 * | 12.33M | EV / Sales 2025 * | 14.1 x |
P/E ratio 2024 * |
-2.13
x | P/E ratio 2025 * |
-2.13
x | Employees | 30 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.53% |
Latest transcript on Clearside Biomedical, Inc.
1 day | +2.52% | ||
1 week | -12.86% | ||
Current month | -12.86% | ||
1 month | -9.63% | ||
3 months | -26.95% | ||
6 months | +11.93% | ||
Current year | +4.27% |
Managers | Title | Age | Since |
---|---|---|---|
George Lasezkay
CEO | Chief Executive Officer | 72 | 17-08-07 |
Charles Deignan
DFI | Director of Finance/CFO | 59 | 11-12-31 |
Susan L. Coultas
CTO | Chief Tech/Sci/R&D Officer | - | 22-06-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
George Lasezkay
CEO | Chief Executive Officer | 72 | 17-08-07 |
Jeffrey Edwards
BRD | Director/Board Member | 63 | 18-09-25 |
Christy Shaffer
BRD | Director/Board Member | 66 | 11-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 1.22 | +2.52% | 229,984 |
24-06-06 | 1.19 | -4.80% | 176,693 |
24-06-05 | 1.25 | -0.40% | 85,022 |
24-06-04 | 1.255 | -2.71% | 107,720 |
24-06-03 | 1.29 | -7.86% | 239,988 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.27% | 91.17M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+2.53% | 22.78B | |
-10.46% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- CLSD Stock